Traders Cafe with Zak Mir: DEV, GUN, CDL, 88E & AVCT via Vox Markets

Shares of Edtech specialist Dev Clever (DEV) bounced back 3.5p to 45p, in the wake of Monday’s Half-Year Report. The financial highlight here was that revenue rose 531% at £2.4m for the Period (H1 2020: £383k) and this was supported by significant contract wins in the Educate division.

By Zak Mir

The company has also been supported by a recent research report from RBSA Advisors, the Indian EdTech market is poised to transform from a $700-800 million market to a $30 billion in size in the next 10 years. Traders also took advantage of a bear trap dip for Dev shares below 40p, as well as the expectation of further significant newsflow from the company which would be worth of a decent re-rate in the stock.

One of the key things investors like to see at investment companies are liquidity events, something that Gunsynd (GUN) managed to offer in December, with no less than three of them. It is at it again, with news that Charger Metals Limited, one of Gunsynd’s investee companies is expected to begin trading on the Australian Securities Exchange (ASX) on Friday 9 July 2021, under the ticker symbol ASX:CHR. Charger Metals successfully raised A$6 million in the IPO capital raising, and Gunsynd will hold 3,600,000 shares in Charger representing approximately 7.14% of the company’s issued share capital. Charger Metals is a Western Australian focused Base metals and Lithium exploration company.

Natural resource project generator Cloudbreak Discovery (CDL) announced that investee company Imperial Helium Corp. in which it owns 1.25 per cent has spud IHC Steveville 1 at 102/03-01-020-12W4M, Imperial Helium’s first well on its Steveville Helium Property, located in Southeastern Alberta, on schedule. IHC Steveville 1 is the first of two appraisal wells Imperial Helium plans to drill on the Steveville structure. Kyler Hardy, CEO of Cloudbreak Discovery, said the company is looking forward to working with Imperial Helium to establish the resource available.

Shares of 88 Energy (88E) rose 0.15p to 2.25p, having been a firm market over the past week. At the beginning of the month the company said it had completed the sale of the Alaskan Oil and Gas Tax Credits for $18.7 million cash. $16.1 million of the sale proceeds were applied to the full repayment of 88 Energy’s outstanding debt with FCS Advisors, meaning that the company is now debt free.

There was perhaps a rather surprising dip in shares of diagnostics group Avacta (AVCT), with the stock back to the 150p’s support area from which they rallied towards 200p last month. At the end of June the company said that a study has shown that the AffiDX® antigen lateral flow test detects the Delta variant of the SARS-CoV-2 virus in clinical samples. In this small study, it outperformed two lateral flow antigen tests that are commercially available in Europe.


Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.